Safety Data Sheet 1. SUBSTANCE/PREPARATION AND COMPANY IDENTIFICATION
Catalogue number: Product name:
Gonococci Selective Supplement Supplement for the production of microbiological culture media
Manufacturer/supplier:
SIFIN Institut für Immunpräparate und Nährmedien GmbH Berlin
2. COMPOSITION, INFORMATION ON INGREDIENTS
Chemical characterisation of the product: Lyophilisate with trimethoprim, lincomycin and polymyxin B Dangerous components:
Description: CAS -No. / EC-No.: Classification: Content (% by weight): 3. HAZARDS IDENTIFICATION Toxic if swallowed.
4. FIRST AID MEASURES
Skin contact:
Eye splashes:
Rinse the ey es with clear running water with the eyelids open.
Inhalation:
Ingestion:
Rinse mouth out and drink copious amounts of water.
In case of indisposition, seek medical advice.
5. FIRE FIGHTING MEASURES
Suitable extinguishing media: Select according to surrounding materials. Special hazards:
The product does not represent a fire hazard, but is flammable.
In the event of fire, toxic vapours may be formed.
SIFIN GmbH Berlin Safety Data Sheet acc. to EU Directive 2001/58/EC 6. SPILLAGE / ACCIDENTAL RELEASE MEASURES
Personal precautions:
A void skin and eye contact. See heading 8: personal protective equipment. Cleaning methods: Collect spilled product dry. Remove for disposal. Clean area afterwards. 7. HANDLING AND STORAGE
Handling:
An effective dust removal system is required.
Containers must be opened and handled with care.
Storage:
Instructions concerning co-storage not required.
Product must be kept under lock and key and be
accessible only to specialists or authorized persons.
8. EXPOSURE CONTROLS, PERSONAL PROTECTION
Components requiring monitoring of workplace exposure limit values: not applicable.
General protective and hygiene measures: Keep product away from food, beverages and animal feed Protective work clothing must be worn. Remove soiled or splashed clothing immediately. Store protective clothing separately. Wash hands before taking a break and when finishing work. During weighing, a dust mask or a good suction dust remover is recommended. Personal protective equipment:
Dust mask is required if dusts are generated.
9. PHYSICAL AND CHEMICAL PROPERTIES:
Physical state: pH-value:
Neutral (for the finished product, see preparation information)
Boiling point: Flash point:
Flammable limits: Vapour density: Specific gravity: SIFIN GmbH Berlin Safety Data Sheet acc. to EU Directive 2001/58/EC 10. STABILITY AND REACTIVITY
Conditions to be avoided:
Substances to be avoided: Hazardous decomposition products:
In the event of fire, toxic vapours may be formed.
11. TOXICOLOGICAL INFORMATION
Toxicological data for the product are not available. The following hazards are associated with this product: Toxic if swallowed.
The toxicological classification of this product is based on calculations made according to the EU Dangerous Preparations Directive (1999/45/EC). Additional toxicological information: Numbers in the "Registry of Toxic Effects of Chemical Substances" RTECS: Lincomycin: RH6314000. Trimethoprim: UV8225000. Polymyxin B: TR1150000 12. ECOLOGICAL INFORMATION
Ecotoxicity: Quantitative data regarding ecological effects of this product are not available. Additional harmful effects: If handled and used appropriately, ecological problems are not expected to occur. 13. DISPOSAL CONSIDERATIONS
Product: There are no uniform regulations concerning disposal of chemicals or unused materials in the EU. Unused chemicals are often classified as "in particular need of control", i.e. as toxic waste. Disposal is regulated by national laws or regulations of the individual EU member states. Please contact the relevant agency (state authority or waste disposal company) for information about disposal. Waste key no. (EWC):
Waste from medical and veterinary care and research;
chemicals composed of or containing hazardous substances.
EWC: European Waste Catalogue. Waste products marked with an asterisk (*) count as hazardous waste according to Directive 91/689/EEC on Hazardous Waste. After use, the processed product contains no components in dangerous concentrations and may be disposed of in household-type commercial waste. However, infection prevention considerations resulting from use of the product may make special disposal necessary. Packaging: Disposal is to be made in accordance with state regulations. Contaminated packaging must be handled in the same way as the product. Unless regulations state otherwise, uncontaminated and completely emptied packaging may be treated as domestic waste or recycled. SIFIN GmbH Berlin Safety Data Sheet acc. to EU Directive 2001/58/EC 14. TRANSPORT INFORMATION
Land transport ADR/RID and GGVS/GGVE: ADR/RID class:
3249 Drug, solid, toxic, n.o.s. (trimethoprim)
Maritime transport IMDG/GGVSee: IMDG/GGVSee class:
Drug, solid, toxic, n.o.s. (trimethoprim)
Air transport ICAO-TI and IATA-DGR: ICAO/IATA class:
Drug, solid, toxic, n.o.s. (trimethoprim)
15. REGULATORY INFORMATION
Labelling according to EU Dangerous Substances Regulations:
Symbol / description:
In case of accident or if you feel unwell, seek medical advice
immediately (show the label whenever possible)
German Regulations: Water Hazard Class: 16. OTHER INFORMATION
The information supplied here is based on our current state of knowledge. This information is intended to describe our products with respect to safety requirements. It implies no guarantee of the properties of those products, nor does it establish any contractual relationship. Changes with respect to the previous version (marked at the margin of the text): respecting the classification made by the original manufacturer; editorial changes Department issuing data sheet: SIFIN Institut für Immunpräparate und Nährmedien GmbH Berlin, Head of Department Culture Media, Tel.: +49 (0) 30 927030-0
Edwin Winkel DDS PhD Actinobacillus actinomycetemcomitans , Bacteroides gingivalis and Bacteroides intermedius : predictors of attachment loss? Wennström JL, Dahlén G, Svensson Svensson J, Nyman S Oral Microbiol. Immunol 1987: 2:158-163 It appeared that the absence of these “indicator” bacteria is a better predictor of no further loss of atta
Guidelines for Pain and Distress in Laboratory Animals: Responsibilities, Recognition and Al eviation Introduction Animals can experience pain and distress. It is the ethical and legal obligation of all personnel involved with the use of animals in research to reduce or eliminate pain and distress in research animals whenever such actions do not interfere with the research objectiv